Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesOther Gross PP&E Adjustments
Ratios

RedHill Biopharma (RDHL) Shares Issued (2016 - 2022)

Historic Shares Issued for RedHill Biopharma (RDHL) over the last 7 years, with Q4 2022 value amounting to $7.6 million.

  • RedHill Biopharma's Shares Issued fell 6173.64% to $7.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was $23.8 million, marking a year-over-year decrease of 6968.78%. This contributed to the annual value of $8.3 million for FY2024, which is 4080.52% down from last year.
  • As of Q4 2022, RedHill Biopharma's Shares Issued stood at $7.6 million, which was down 6173.64% from $15.5 million recorded in Q2 2022.
  • In the past 5 years, RedHill Biopharma's Shares Issued ranged from a high of $57.9 million in Q1 2021 and a low of $273000.0 during Q2 2021
  • Over the past 4 years, RedHill Biopharma's median Shares Issued value was $8.4 million (recorded in 2020), while the average stood at $13.0 million.
  • Within the past 5 years, the most significant YoY rise in RedHill Biopharma's Shares Issued was 558058.61% (2022), while the steepest drop was 9876.94% (2022).
  • Quarter analysis of 4 years shows RedHill Biopharma's Shares Issued stood at $18.3 million in 2018, then tumbled by 54.4% to $8.4 million in 2020, then soared by 136.92% to $19.8 million in 2021, then plummeted by 61.74% to $7.6 million in 2022.
  • Its Shares Issued stands at $7.6 million for Q4 2022, versus $15.5 million for Q2 2022 and $713000.0 for Q1 2022.